TechnoDerma Medicines Inc.
PrivateLast Round
Series B
Jan 14, 2024
Company Overview
TechnoDerma Medicines Inc. is a clinical-stage biopharmaceutical company that develops innovative small molecule drugs for the treatment of androgenic alopecia, eczema/atopic dermatitis, psoriasis, and lupus.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TechnoDerma Medicines Inc. Comparables
Compare TechnoDerma Medicines Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Veradermics Inc. | 84% | |
| Lynk Pharmaceuticals | 83% | |
| Amplifica Holdings Group, Inc. | 81% |
TechnoDerma Medicines Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 14, 2024 | ||||
| Series A Extension | Jan 13, 2023 | ||||
| Series A | Apr 14, 2021 |
TechnoDerma Medicines Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Investments | Series A |
| Zoo Capital | Series B |
| Oceanpine Capital | Series A |
| Viva BioInnovator | Series A Extension, Series B, Series A, Accelerator |
| Chengdu Hi-tech Investment Group Co., Ltd. | Series A Extension |
| CDH Investments | Series A |
| Lingdao Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 14, 2024
Raised Series B with Viva BioInnovator and Zoo Capital.
- Apr 14, 2021
Led by CDH Investments with participation from Lingdao Capital.
TechnoDerma Medicines Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TechnoDerma Medicines Inc.'s valuation, stock price, and market status.
Is TechnoDerma Medicines Inc. a public or private company?
TechnoDerma Medicines Inc. is a private company.
What is the current stock price of TechnoDerma Medicines Inc.?
TechnoDerma Medicines Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is TechnoDerma Medicines Inc. worth (valuation)?
Valuation information for TechnoDerma Medicines Inc. is not publicly available.
Can I buy TechnoDerma Medicines Inc. stock?
TechnoDerma Medicines Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TechnoDerma Medicines Inc.'s last funding round?
TechnoDerma Medicines Inc.'s most recent funding round was Early Funding on January 15, 2024.
Who are the main investors in TechnoDerma Medicines Inc.?
Key investors in TechnoDerma Medicines Inc. include CDH Investments.
Will TechnoDerma Medicines Inc. IPO soon?
No public IPO plans have been announced for TechnoDerma Medicines Inc..
How can I track TechnoDerma Medicines Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TechnoDerma Medicines Inc.'s secondary market activity and sign up for updates.